Short Term Execution is Key
Can they sell their software/methods system and enough synthetic Ibogaine to at least get good terms for the next financing round? It's hard to buy this when another dilution is probably coming. They don't have much cash left. I'm pulling for them, but it gets down to some crisp execution in the very short term.